Position
Chief Executive Officer
Company
Beacon Therapeutics
Description
Beacon Therapeutics Holdings Limited announced the appointment of Lance Baldo, MD as Chief Executive Officer, effective August 12, 2024, and Thomas Biancardi as Chief Financial Officer, effective August 1, 2024, following a $170 million Series B fundraise. The outgoing CEO, Dave Fellows, will assume the role of non-Executive Chairman of the Board in January 2025.
Quick answer
Beacon Therapeutics Appoints Lance Baldo as CEO and Thomas Biancardi as CFO (July 24, 2024).
- Who is the new Chief Executive Officer at Beacon Therapeutics?
- Beacon Therapeutics named Lance Baldo Chief Executive Officer, announced July 24, 2024.
- What did Beacon Therapeutics announce on July 24, 2024?
- Beacon Therapeutics Holdings Limited announced the appointment of Lance Baldo, MD as Chief Executive Officer, effective August 12, 2024, and Thomas Biancardi as Chief Financial Officer, effective August 1, 2024, following a $170 million Series B fundraise. The outgoing CEO, Dave Fellows, will assume the role of non-Executive Chairman of the Board in January 2025.
- What does Beacon Therapeutics do?
- Beacon Therapeutics is a clinical-stage biotechnology company with a mission to save and restore the vision of patients with blinding retinal diseases.
- Which similar companies made leadership changes around the same time?
- NYU Langone Health (July 25, 2024), BeiGene Ltd (July 18, 2024), Nouscom (July 17, 2024) and Alkeus Pharmaceuticals (July 16, 2024) also announced leadership changes within 45 days of Beacon Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- NYU Langone Health's Perlmutter Cancer Center Names Jonathan M. Gerber, MD, as Chief Clinical Officer (July 25, 2024)
- BeiGene Appoints Aaron Rosenberg as Chief Financial Officer (July 18, 2024)
- Nouscom promotes Tiffany Muller to Chief Financial Officer (CFO) and Loredana Siani, Ph.D., to Senior Vice President (SVP), Technical and CMC Development (July 17, 2024)
- Alkeus Pharmaceuticals Appoints Tamara Dillon as Chief Human Resources Officer (July 16, 2024)
- Avalo Therapeutics, Inc. appoints Mittie Doyle as Chief Medical Officer (July 16, 2024)
- Jade Biosciences Names Andrew King as Chief Scientific Officer (August 1, 2024)
Who to call at Beacon Therapeutics, and when
A new leader at Beacon Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Beacon Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Beacon Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Beacon Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Beacon Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Beacon Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.